Last updated 2026-09-03
- Raised Seed Extension led by Startup Intros, Feb 2026
- Raised Seed round led by 1 more investor, Sep 2022
Total raised
—
Last: Grant 2023-11
Stage
Pre-Seed
Founded
2016
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
VenoVision provides a low-cost, easy-to-use, thermal imaging-based hemodynamic monitoring device and platform for the entire continuum of care—inpatient, outpatient, and home settings. It aims to reduce preventable deterioration and rehospitalizations for millions of heart failure and at-risk patients by providing medical teams with hemodynamic data to adjust therapy in time. The company's technology uniquely overcomes the challenges of monitoring obese patients. VenoVision was conceptualized in the Hebrew University of Jerusalem's BioDesign program, was a MassChallenge Israel 2021 Finalist, and is a Health Wildcatters Dallas accelerator (Dallas, USA) 2022 portfolio company. VenoVision won "most innovative" award at M2D2 Impact 2023.
Funding history · 2 rounds · — total
2 events/rounds · — Total Funding
Feb 2026
★ Startup Intros
Sep 2022
Seed
Undisclosed
tracxn.com
Offices
Jerusalem, Israel · HQ / main office
Show all offices (1 more)
- United States
Q&A
- What is VenoVision's primary focus?
- VenoVision provides a low-cost, easy-to-use, thermal imaging-based hemodynamic monitoring device and platform for continuous care settings, aiming to reduce preventable deterioration and rehospitalizations for heart failure and at-risk patients.
- How many employees does VenoVision currently have?
- VenoVision has 1-10 employees.
- When was VenoVision founded?
- VenoVision was founded in January 2016.
- What was VenoVision's most recent funding round?
- VenoVision secured a Grant round in November 2023, raising $7,500.
- What is the total amount of funding VenoVision has raised to date?
- VenoVision has raised a total of $187,500 to date.
- Has VenoVision received any notable awards or recognitions?
- VenoVision won the "most innovative" award at M2D2 Impact 2023.
- Is VenoVision involved with any accelerator programs?
- VenoVision was a Health Wildcatters Dallas accelerator portfolio company in 2022 and was selected for the MassChallenge 2023 HealthTech Cohort.
- What is VenoVision's product stage?
- VenoVision's product is in the clinical trial stage.
Team · 5
Nadav Lankin
Founder · Co-founder
Dr. Tal Hasin
Founder · Co-founder
Prof. Yaakov Nahmias
Founder · Co-founder
Jonathan Maron
Founder · Co-founder
Dr. Yevgeni Plotkin
Medical Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Highlights
1 PatentsVerified
Tags
obesityhospitalsmedical-technologiesearly-detectiondoctorshome-caremedical-devicescritical-carecardiovascularartificial-intelligenceremote-monitoringdigital-healthcareheart-failurecardiologythermal-imagingmonitoringnon-invasivealert-systemdecision-supporthealthcare-providers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | venovision.com/ |
|---|---|
| linkedin.com/company/85630381 |
Identifiers & details
| Founded | 2016-1 |
|---|---|
| Employees (exact) | 1 |
| Offices | United States |
Radar intelligence
Web history (Wayback)
| Domain | venovision.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|